skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong’s Manufacturing Facility for Nabota acquires EU GMP Approval
Date 2018-06-19 Hit 1353
News List
Prev The Nabota Manufacturing Facility acquires GMP Approval from Health Canada
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval